Genmab | GEN - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Agios Pharmaceuticals 3.56 0 2026-03
Almirall 79.43 0.3 2025-12
Amarin 91.05 88.3 2023-06
Amgen 18.07 1.77 2026-06
argenx SE 35.53 3.41 2026-06
AstraZeneca 25.34 4.25 2026-06
Bayer 4.14 0.74 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Demant 27.46 7.1 2025-12
Exelixis 18.02 4.11 2026-06
Fresenius Medical Care 12.13 5.49 2026-06
Genmab 16.04 1.05 2026-06
GlaxoSmithKline 10.63 4.24 2026-06
GN Store Nord 10.77 12.24 2026-03
GRIFOLS 14.71 3.73 2026-06
Hikma Pharmaceutical 10.43 3.72 2025-12
Lakefront Biotherapeutics 2.68 0.14 2026-06
Lonza 34.34 2.58 2025-12
Merck 17.21 4.47 2026-06
Novartis 22.41 2.24 2026-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Roche Holding 16.48 0.39 2026-06
Sanofi 18.96 7.12 2026-06
UCB 29.7 5.52 2025-12